The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of industry relationships in oncology.
 
Rebecca A. Harrison
No Relationships to Disclose
 
Nazanin Majd
Consulting or Advisory Role - Baxter (I); Celularity; Sumitomo Dainippon Pharma Co., Ltd. Consulting
 
Margaret O. Johnson
No Relationships to Disclose
 
Diana L. Urbauer
No Relationships to Disclose
 
Vinay K. Puduvalli
Stock and Other Ownership Interests - Amarin Corporation; Gilead Sciences
Honoraria - Novocure; Orbus Therapeutics; SERVIER
Consulting or Advisory Role - Newave Pharmaceutical (I); NewBio; Novocure; Orbus Therapeutics; SERVIER
Research Funding - BeiGene; Bexion; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Merck; Radiomedix; Samus Therapeutics; SERVIER
 
Mustafa Khasraw
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Janssen; Lilly; Roche
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech